A distributor of herbal medicines has been fined US$600 for selling drugs that lacked approval. The company appeared through its manager, Nyaradzo Chawira, who is 45, and entered a guilty plea. The charge concerned violations of the Medicines and Allied Substances Control Act, the law governing which products may be sold as medicine. Unapproved drugs reach consumers without any assessment of safety or efficacy. The fine is modest in hard currency terms, though it still lands on the company's record. Enforcement of this kind is how regulators try to keep unlicensed remedies off the shelves. The case was reported by Newsday.